#United States #pharmaceutical #AI Intelligence #Tiburon #ProclaimRx

ProclaimRx Unveils Innovative AI Platform Revolutionizing Pharmaceutical Decision-Making

On October 17, 2025, ProclaimRx™ has officially launched its cutting-edge AI platform designed to elevate decision-making in the pharmaceutical industry. This enterprise-grade solution is engineered to convert an overwhelming amount of pharmaceutical data into real-time, actionable insights, significantly reducing the time taken for analysis and enhancing commercial outcomes for its users.

A Smarter Approach to Data Management

ProclaimRx leverages its proprietary PLAiTO™ Intelligence Engine, which can streamline tasks that typically consume teams hours of effort weekly. By automating the analysis of brand and sales data, it reclaims up to 15 hours of work time each week, freeing teams to focus on strategic decision-making rather than getting lost in data.

Eugene Lee, the newly appointed Chief Commercial Officer (CCO), articulated the platform's purpose succinctly: “ProclaimRx addresses one of life sciences' biggest challenges—turning complex information into actionable commercial intelligence.” This innovative tool positions commercial teams to transition from data to decisions in seconds, not months.

Key Features and Benefits

The release of ProclaimRx marks a significant advancement in the way pharmaceutical companies can approach marketing and sales strategies. Here are some of the primary benefits that the platform offers:

- Automated Insights: By providing on-demand simulations and models, ProclaimRx empowers companies to make informed investment decisions quickly.
- Enhanced Data Utilization: The platform taps into ProclaimRx's proprietary database, unlocking richer insights and performance benchmarks that are vital for effective strategy formulation.
- Conflict-Free Security: Designed with enterprise security as a priority, ProclaimRx ensures that no data is shared with third parties, safeguarding sensitive commercial information.

Leadership Driving Change

As part of this significant corporate advancement, ProclaimRx also announced the recruitment of seasoned professionals to guide the company’s growth. Kathy Contratto has been named the Vice President of Customer Operations. Both leaders come equipped with extensive experience from their tenures in various healthcare organizations, proving their capability to drive transformational growth at ProclaimRx.

ProclaimRx's CEO, Jim Cronin, stated, “We built a solution tailored for pharma leaders to make better decisions faster and with increased confidence.” This commitment to enhancing pharmaceutical marketing strategies highlights ProclaimRx's role as a vital partner in the industry.

Participation in Pharma CX Marketing Summit

ProclaimRx will participate in the upcoming Pharma CX Marketing Summit held in Philadelphia from October 20-21, 2025. The team is set to conduct live demonstrations and lead an interactive panel discussion focusing on how commercial teams can effectively utilize AI to glean real-time insights and expedite the transition from data to decisions.

Attendees are encouraged to engage with the ProclaimRx team, explore firsthand the impressive capabilities of the platform, and sign up for early access to upcoming pilot projects and potential partnerships. Scheduling meetings or demos can be done via their official website.

About ProclaimRx

ProclaimRx is at the forefront of AI commercial intelligence solutions, specifically tailored for pharmaceutical sales and marketing leaders. Unlike generic analytics tools, ProclaimRx processes both structured and unstructured data using advanced Natural Language Processing (NLP). This enables it to deliver real-time, data-driven recommendations designed to refine brand plans, target customers effectively, and optimize campaigns and budgets.

For more detailed information about ProclaimRx and its offerings, you can visit their official website at www.ProclaimRx.com or follow them on LinkedIn for regular updates and insights.